Multifaceted guideline implementation strategies improve early identification and management of osteoporosis

Kimber, Cheryl; Grimmer, Karen

doi:10.1071/ah090423

Cited by 8 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The HARS-14 and CHDS scores of the anxiety–depression group were significantly higher than the control group ( P < 0.001) whereas the E2 and progesterone levels were significantly lower ( P < 0.001). The cut-off score for the statistics in Table 2 is 27 (mild cognitive difficulty [21]. An ANCOVA rank sum test (variance arrhythmias) showed that the C-MMSE score in the anxiety–depression group was significantly lower than the control group ( P < 0.01).…”

Section: Resultsmentioning

confidence: 99%

“…The organic diseases diagnosis was based on the 2007 ESH-ESC (European Society of Hypertension-European Society of Cardiology) Practice Guidelines [19], the 2009 Osteoporosis Guidelines [20, 21] and the standard for early detection of dementia, including mild cognitive impairment [22], blood pressure, poor recognition ability and low bone density. Our study used the Chinese Mini Mental State Examination (C-MMSE) [23, 24] to assess the patient recognition function and the Fan Beam X-ray Bone Densitometer to assess bone density.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorder

Zhou

Sun

Zhang³

et al. 2011

Arch Gynecol Obstet

View full text Add to dashboard Cite

PurposeTo explore whether the symptoms of climacteric syndrome associated with its physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorder.MethodsWe recruited 78 climacteric patients with anxiety–depression disorder and 72 control participants in perimenopausal/postmenopausal without anxiety–depression disorder for this study. We measured symptoms using the Greene Climacteric Symptom Scale in all cases. We also collected demographic data and tested sexual hormone, blood pressure, bone density, cognitive, estrogen receptor-alpha (ERα) gene polymorphism as physiological factors, using HARS-14 and CHDS assessed psychological disorder degree.ResultsC-MMSE scores as well as Estradiol and progesterone levels in the anxiety–depression disorder group were significantly lower compared to the control group (P < 0.01). In addition, the anxiety–depression disorder group had significantly higher Greene Climacteric Scale scores, as well as somatic symptoms compared to controls (P < 0.01). Moreover, the anxiety, depression and somatic symptoms of the Greene Climacteric Scale were positively correlated with HARS-14 and CHDS scores (P < 0.001) and negatively with estrogen level and C-MMSE scores (P < 0.05) in the anxiety–depression disorder group. Greene Climacteric Scale Symptoms were not significantly correlated with blood pressure, bone density or other factors (P > 0.05). There was no significant change in the allele frequency or the estrogen receptor-alpha gene polymorphisms, between the two groups (P > 0.05); however, the Pp genotype was negatively associated with C-MMSE scores (r = appraises, P = 0.033).LimitationsThe sample size was relatively small.ConclusionsThe symptoms of somatic symptoms in patients with climacteric syndrome and anxiety–depression disorder are associated with the emotional disorder but not with a physical disease. The Pp ERα polymorphism Pvu II is associated with a cognitive decrease.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorder

Zhou

Sun

Zhang³

et al. 2011

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

“…Adherence to evidence-based management recommendations is associated with improvement in patient outcomes [ 12 ]. Strategies employed to improve the implementation and use of osteoporosis guidelines have also been shown to result in management plans becoming aligned with best practice [ 13 ]. APCO has identified the following key gaps in osteoporosis screening, diagnosis and in consistent delivery of osteoporosis care in the Asia Pacific region: Clinical guidelines relating to osteoporosis in the Asia Pacific are either unavailable and if they are, are heterogenous in terms of their scope and recommendations made.…”

Section: The Priority Initiative Of Apcomentioning

confidence: 99%

IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific

et al. 2020

View full text Add to dashboard Cite

Summary Asia Pacific Consortium on Osteoporosis (APCO) comprises of clinical experts from across the Asia Pacific region, uniting to develop solutions to problems facing osteoporosis management and care. The vision of APCO is to reduce the burden of osteoporosis and fragility fractures in the Asia Pacific region. Introduction The Asia Pacific (AP) region comprises 71 countries with vastly different healthcare systems. It is predicted that by 2050, more than half the world’s hip fractures will occur in this region. The Asia Pacific Consortium on Osteoporosis (APCO) was set up in May 2019 with the vision of reducing the burden of osteoporosis and fragility fractures in the AP region. Methods APCO has so far brought together 39 clinical experts from countries and regions across the AP to develop solutions to challenges facing osteoporosis management and fracture prevention in this highly populous region of the world. APCO aims to achieve its vision by engaging with relevant stakeholders including healthcare providers, policy makers and the public. The initial APCO project is to develop and implement a Framework of pan-AP minimum clinical standards for the screening, diagnosis and management of osteoporosis. Results and conclusions The Framework will serve as a platform upon which new national clinical guidelines can be developed or existing guidelines be revised, in a standardised fashion. The Framework will also facilitate benchmarking for provision of quality of care. It is hoped that the principles underlying the formation and functioning of APCO can be adopted by other regions and that every health care facility and progressively every country in the world can follow our aspirational path and progress towards best practice.

show abstract

A cohort study of osteoporosis health knowledge and medication use in older adults with minimal trauma fracture

et al. 2012

View full text Add to dashboard Cite

show abstract

Multifaceted guideline implementation strategies improve early identification and management of osteoporosis

Abstract: Background: Osteoporosis contributes significantly to fractures, subsequent disability and premature mortality in Australia. Better detection and management of osteoporosis will reduce unnecessary health expenditure.

Cited by 8 publications

References 18 publications

The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorder

The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety–depression disorder

IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific

A cohort study of osteoporosis health knowledge and medication use in older adults with minimal trauma fracture

Contact Info

Product

Resources

About